SIG: Real-World Evidence (RWE) Collaborative

 View Only

Strategic Collaborations and Outreach

  • 1.  Strategic Collaborations and Outreach

    Posted 10-02-2020 12:25
    This discussion board is to review the outreach strategy for ISPE RWE Task Force RWD and Oncology Team to collaborate with national and international organizations, professional societies, and relevant oncology RWD stakeholders to facilitate the exchange of ideas.

    The priority outreach strategy is going to begin with the organizations, with the goal of expansion:
    I.     ASCO (Donna)
    II.    ESMO (Michael)
    III.   FOCR (Donna)
    IV.    AACR (Leah)

    Other recommendations for outreach include:
    • Academy of Medical Sciences/ ABPI
    • IARC
    • ENCR
    • NAACCR
    • ASH
    • SIOG
    There was a recent suggestion to assess the feasibility of a Joint Committee or council of these organizations on pharmacoepidemiology. 

    If you have suggestions on additional collaborations of interest or the idea of a Joint Committee, please reply to the discussion.

    We invite your ideas! Thank you!

    ------------------------------
    Donna Rivera PharmD, MSc.
    Associate Director of Pharmacoepidemiology
    US Food and Drug Administration
    javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions("ctl00$MainCopy$ctl02$PostMessageContent$BtnSave", "", true, "", "", false, true))
    ------------------------------